Executive Order 12564: Drug-Free Federal Workplace

Why it was signed

President Reagan signed EO 12564 on September 15, 1986; the National Archives identifies its Federal Register publication as 51 FR 32889 on September 17. The opening findings state the administration's reasons for acting, including concerns about employee performance, safety, and security. Those are presidential policy claims, not measured outcomes established by the order. The operative provisions that follow govern executive-branch employment, so the guide does not treat the order as a general prohibition applying to every U.S. worker. Archived order text and publication citation.

The order named Title 5 civil-service authorities and a public-health statute among its bases. It combined a prohibition on illegal drug use by federal employees, including off-duty use, with agency programs for education, employee assistance, rehabilitation, and carefully controlled testing. The scope of a particular employee's duties or testing depends on the text, the agency's approved plan, implementing guidelines, and applicable law. Treating the order as an instruction to test every employee would misstate the policy it prescribed. EO 12564, preamble and sections 1–3.

What the text authorized

Section 1 made refraining from illegal drug use, on or off duty, a condition of federal employment. Section 2 directed executive-agency heads to develop a plan and include statements of policy, employee education, supervisor training, employee assistance, and procedures to identify illegal use. The plan was an agency obligation: the executive order did not itself name every position for testing, publish an agency laboratory protocol, or decide individual disciplinary cases. EO 12564, sections 1–2.

The testing provisions identified circumstances such as employees in sensitive positions, reasonable suspicion of use, accidents or unsafe practices, and follow-up during or after counseling or rehabilitation. The order also addressed a voluntary-testing option. Its testing plan was to respect privacy, confidentiality, and reliability, and agencies had to follow the scientific and technical guidance required by the order. Each category has a different predicate. No reader should infer from the mere existence of a program that every federal employee was randomly tested. EO 12564, sections 2–3 and 5.

For employees found to use illegal drugs, the order called for referral to an employee-assistance program. It also set out circumstances for disciplinary action and removal, while distinguishing an employee who voluntarily identified a problem and obtained help before testing from one found through a test. This is an employment framework with procedures and exceptions, not an automatic finding of misconduct from any allegation. Agency decisions must still be assessed against the order, applicable civil-service rules, and the evidentiary record in the particular case. EO 12564, sections 3–5.

What happened in practice

Congress enacted the Federal Employee Substance Abuse Education and Treatment Act in 1986 as part of Public Law 99-570. OPM describes 5 U.S.C. 7361–7362 and 5 CFR part 792 as requiring prevention, treatment, and rehabilitative services for civilian employees. Those statutory and regulatory duties are distinct from, and complement, the presidential workplace directive. A full account must therefore separate what Reagan ordered in September from what Congress enacted later that year and from the agency rules that administer assistance programs. OPM legislation guide; EO 12564.

OPM's employee-assistance guidance continues to describe a federal executive-branch drug-free workplace program grounded in EO 12564. It identifies five components: agency policy, assistance and referral, supervisor training, confidential self-referral where possible, and carefully monitored identification including testing. This is later evidence that the order remained an operational basis for federal employer programs; it is not proof of the number of tests, positive results, referrals, or removals in any single agency. Such quantitative claims would require agency or SAMHSA datasets. OPM Employee Assistance Programs.

OPM identifies SAMHSA as the agency providing technical assistance on federal drug testing, medical review, laboratory certification, and plan review. It says SAMHSA enforces mandatory testing guidelines and coordinates review of agency plans under the order. This division of responsibilities explains why current scientific testing standards cannot be read from the 1986 presidential text alone. A claim about a modern specimen type, test cutoff, or privacy safeguard must be checked against the applicable HHS guidelines and agency plan. OPM legislation and agency-responsibilities guide.

Reaction and legacy

The official OPM health-and-wellness page still says EO 12564 requires agencies to establish a drug-free federal workplace program. That is a current agency account of the order's role, not a blanket certification that every agency has complied with every detail since 1986. It also does not extend the order to private employers. The continued program and any particular employment dispute should be evaluated separately, using current agency rules and legally applicable testing standards. OPM Health and Wellness; OPM assistance guide.

The most useful distinction for readers is between the order's condition of federal employment, the agency plans that implemented it, and later law governing assistance and testing. The presidential findings explain why the administration adopted the policy, but they do not by themselves establish that it reduced drug use or improved productivity. OPM's materials substantiate continued administration, while outcomes for a specific agency or employee require more particular evidence than a site-wide guide can provide. EO 12564; OPM legislation guide.

A federal workplace program and individual procedures

EO 12564 declared a drug-free federal workplace policy and directed executive agencies to develop programs addressing illegal drug use. It described testing for certain positions and circumstances, while requiring procedures and safeguards. It did not establish the same rule for every private employer or make every positive result an automatic final judgment about an employee. NARA EO 12564.

The order’s coverage turns on federal employment and an agency’s implementing plan. Sensitive positions and reasonable-suspicion circumstances can involve different tests and procedural requirements. A particular employee’s case requires the applicable plan, regulation and factual record, not a general headline about compulsory testing. EO 12564.

The text addressed confidentiality, employee assistance and the consequences of illegal drug use in a federal job. These features mean the program cannot be described only as punitive or only as treatment. The operative requirements and later agency practice determine the balance in a given case. NARA text.

OPM continues to list the order in its account of federal employee wellness and drug-free workplace policy. That institutional reference supports its continuing relevance but is not a substitute for current agency procedures or later statutory rules. A present-day employee should look to those specific materials. OPM legislation and policy.

A legal challenge to testing can also involve constitutional privacy principles and statutory protection. EO 12564 supplies executive direction; it does not predetermine the result of every challenge or authorize testing outside lawful limits. Avoid generalizing from one position to every federal worker. EO 12564.

Assessing effectiveness would require program data and credible measures of safety and employee outcomes. The order establishes a goal and mechanism, while the effectiveness claim is empirical. The guide’s status can accurately reflect the program’s continuing presence without implying that every original agency plan remains identical. OPM policy; NARA order.

The agency plan behind a test

EO 12564 directed agencies to establish drug-free workplace programs, including criteria for testing sensitive positions and other specified circumstances. The operative agency plan determines how an employee is selected, notified and supported. The presidential document should not be used as a substitute for those procedures in an individual case. NARA EO 12564.

Positions involving safety, security or public trust can be treated differently from ordinary roles. The order’s categories and later agency determinations matter. An assertion that all federal staff were randomly tested at the same frequency would require evidence not supplied by the order. EO 12564.

Employee assistance is part of the framework, alongside restrictions and possible discipline. Describing the policy as a purely punitive purge omits that element; describing it as voluntary treatment omits compulsory testing in covered situations. The balance should be established from text and the particular agency program. NARA text.

Testing raises questions of reliable procedures, confidentiality and employee rights. The order directs executive policy within law, not immunity from constitutional or statutory challenge. A court case or personnel appeal has its own facts and holding. EO 12564.

Continuity with later workplace policy

OPM still cites EO 12564 in federal employee policy material. That supports the conclusion that the order remains relevant, but readers should also consult updated agency plans and regulations. An OPM summary does not imply every 1986 practice persists unchanged. OPM legislation page.

A positive test, a determination of illegal use and a personnel consequence are separate stages. The order should not be paraphrased as automatically firing anyone with a single result. Applicable review and assistance provisions can matter. NARA EO 12564.

Program success would be measured with credible safety, compliance and employee data, accounting for selection of sensitive roles. The order’s existence is not a statistical demonstration of fewer accidents or better health. EO 12564.

The boundary between federal and private employment is another common source of confusion. A private employer may face separate drug-testing laws and contract rules; this order directly manages executive-branch federal workforce policy. NARA EO 12564.

The statutory and health framework

Congress enacted the Federal Employee Substance Abuse Education and Treatment Act in 1986. OPM discusses its provisions, 5 U.S.C. 7361–7362 and 5 CFR part 792, alongside the executive order. The statute, regulation and EO should not be collapsed into a single presidential directive. OPM legislation history.

OPM identifies components of agency programs including policy, employee assistance, supervisory training, education and testing. These show a program broader than testing alone. The details of a specific agency’s practice still require its plan. OPM workplace guidance.

OPM also describes SAMHSA technical assistance for medical review, laboratory certification and testing plans. This later administrative structure is an important part of implementation but is not a clause to be attributed verbatim to the 1986 order. OPM employee wellness.

Current agency references support the order’s continuing relevance, while a current employee’s rights and duties require the live agency rules. Historical origins and present implementation are different questions. NARA EO 12564.

Five different program elements

OPM describes agency policy, employee assistance, supervisory training, education and testing as components of a drug-free federal workplace. A summary about random testing alone would omit most of the program context. The exact rules for a job reside in the agency plan. OPM workplace guidance.

OPM also links the order to the 1986 employee substance-abuse statute and implementing regulation. Those legal sources should be separately identified when a guide discusses treatment or workplace assistance. OPM legislation page.

SAMHSA’s technical role in federal testing illustrates implementation beyond the initial presidential text. Laboratory standards and medical review cannot safely be inferred from a short summary of EO 12564. OPM guidance.

An individual personnel outcome still requires facts and procedural records. The order establishes a workplace requirement, not automatic proof that a disputed test was properly conducted. NARA EO 12564.

The employee’s record

A federal worker’s testing question would require the agency plan, position designation, reason for selection, laboratory and medical-review process, and applicable personnel rules. EO 12564 directs the program but does not supply these facts for a person. NARA EO 12564.

OPM’s account places assistance, education and training alongside testing. This combined design is part of the policy history, and omitting it would misstate the order as solely a laboratory rule. OPM guidance.

The separate 1986 statute and regulations also affect agency responsibilities. A current employee should consult those sources and live agency instructions, not assume the original executive text is a complete procedural code. OPM legislation.

What a program listing proves

OPM’s current reference to EO 12564 confirms its ongoing role in federal workplace policy. It does not prove that every agency’s testing plan is identical or that every test complies with its rules. OPM legislation.

The concurrent 1986 statute, implementing regulation and agency plans can add detail to the executive framework. A present employee should use those live sources to understand assistance, review and personnel consequences. OPM guidance.

The separation of sensitive-position testing, reasonable suspicion and employee-assistance pathways is more than a drafting detail. It can determine whether a particular worker was selected lawfully and what support was available. OPM’s account of agency programs and SAMHSA technical review supplies implementation context that the executive order’s short summary cannot. OPM federal workplace policy; EO 12564.

Common questions

Did EO 12564 cover private-sector employees?

No. Its operative duties concern federal executive agencies and federal employees. Private employers may face other laws or adopt their own policies, but this particular presidential directive cannot be used as proof that a private worker is subject to a federal agency testing plan. EO 12564, sections 1–2.

Did the order require random testing of every federal employee?

No. Its testing provisions and agency-plan process distinguished categories and circumstances, including sensitive positions and situations involving reasonable suspicion or an accident. An employee's actual testing terms require the applicable agency plan and current scientific guidelines. OPM describes testing as controlled and carefully monitored. EO 12564, sections 2–3; OPM assistance guidance.

Does the workplace program still exist?

OPM currently describes the order as requiring agency programs and lists assistance, training, confidentiality, and testing components. That supports the status of an ongoing federal employer framework. It does not determine an individual test result or mean all parts of the 1986 text are the only governing rules today. OPM Health and Wellness; OPM legislation guide.